Cowen Inc’s Acadia Pharmaceuticals ACAD Stock Holding History

Cowen Inc’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-7,500	Closed	-$115K	–	502
2018 Q2	$115K	Buy	+7,500	New	+$134K	﹤0.01%	356
2016 Q3	–	Sell	-17,500	Closed	-$568K	–	230
2016 Q2	$568K	Buy	+17,500	New	+$586K	0.04%	155
2016 Q1	–	Sell	-9,480	Closed	-$338K	–	253
2015 Q4	$338K	Buy	+9,480	New	+$334K	0.02%	224
2015 Q3	–	Sell	-5,000	Closed	-$209K	–	250
2015 Q2	$209K	Sell	5,000 -36,300	-88%	-$1.4M	0.01%	360
2015 Q1	$1.35M	Buy	+41,300	New	+$1.42M	0.11%	111

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Cowen Inc's ACAD Position: Q3 2018 in Review

Cowen Inc sold out of Acadia Pharmaceuticals (ACAD) in Q3 2018, closing a stake of 7,500 shares — an estimated $115K sold.

Cowen Inc first reported a position in ACAD in Q1 2015 and held it in 5 quarters. The position peaked at $1.35M in Q1 2015. 184 funds tracked by Wall St. Rank hold ACAD as of Q3 2018.

Cowen Inc reported no remaining Acadia Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Cowen Inc sold 7,500 Acadia Pharmaceuticals shares in Q3 2018, an estimated $115K.
Cowen Inc first reported a position in Acadia Pharmaceuticals in Q1 2015 and held it in 5 quarters.
Cowen Inc's Acadia Pharmaceuticals position peaked at $1.35M in Q1 2015.
184 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2018.

Based on Cowen Inc's 13F filing for Q3 2018, filed 13 Nov 2018.